Suppliers must comply with the Quality System Regulation, which governs the design, testing, production, processes, controls, quality assurance, labeling, packaging, and shipping of medical devices. Both domestic and foreign manufacturing facilities are subject to inspections by the U.S. Food and Drug Administration (FDA). Marketing products outside the United States requires adherence to various international regulatory requirements, including those of the European Union. These requirements involve conducting preclinical studies, clinical trials, and submitting marketing authorization applications. Non-clinical studies must comply with Good Laboratory Practice (GLP) standards according to EU Directive 2004/10/EC and OECD guidelines. The European Union's Clinical Trials Regulation (EU) No 536/2014, effective January 31, 2022, facilitates clinical trial approvals through a single application submitted via the Clinical Trials Information System, which is overseen by the European Medicines Agency (EMA).
Generation Bio Co's Comment on Supply Chain
Suppliers must comply with the Quality System Regulation, which governs the design, testing, production, processes, controls, quality assurance, labeling, packaging, and shipping of medical devices. Both domestic and foreign manufacturing facilities are subject to inspections by the U.S. Food and Drug Administration (FDA). Marketing products outside the United States requires adherence to various international regulatory requirements, including those of the European Union. These requirements involve conducting preclinical studies, clinical trials, and submitting marketing authorization applications. Non-clinical studies must comply with Good Laboratory Practice (GLP) standards according to EU Directive 2004/10/EC and OECD guidelines. The European Union's Clinical Trials Regulation (EU) No 536/2014, effective January 31, 2022, facilitates clinical trial approvals through a single application submitted via the Clinical Trials Information System, which is overseen by the European Medicines Agency (EMA).
Sources:
Generation Bio Co 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Generation Bio Co ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
